This inventor holds 1 USPTO granted patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Arno Appavoo Enose: Innovator in Antimalarial Research
Introduction
Arno Appavoo Enose is a notable inventor based in Kanyakumari, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimalarial medications. His innovative work has led to advancements that could potentially improve treatment options for malaria.
Latest Patents
Arno Appavoo Enose holds a patent for "Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials." This invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs, and analogues. The patent emphasizes that the water content of the dosage form is not more than 6.5% w/w, which is crucial for maintaining the stability and efficacy of the medication.
Career Highlights
Arno Appavoo Enose is currently associated with Ranbaxy Laboratories, Inc., a prominent player in the pharmaceutical industry. His work at the company has allowed him to focus on innovative solutions for combating malaria, a disease that continues to affect millions worldwide.
Collaborations
Some of his notable coworkers include Harish Kumar Madan and Sumit Madan. Their collaboration has likely contributed to the success of various projects within the company.
Conclusion
Arno Appavoo Enose's contributions to antimalarial research highlight the importance of innovation in the pharmaceutical industry. His patent and ongoing work at Ranbaxy Laboratories, Inc. demonstrate his commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
